SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363)

PHASE3CompletedINTERVENTIONAL

Enrollment

198

Participants

Timeline

Start Date

November 1, 2005

Primary Completion Date

May 1, 2006

Study Completion Date

May 17, 2006

Conditions

Asthma

Interventions

DRUG

MK0476, montelukast sodium / Duration of Treatment: 8 Weeks

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00445107 - SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363) | Biotech Hunter | Biotech Hunter